The medtech segment achieved operational revenue growth of 4.4% despite ongoing weaknesses in the Chinese market. Notably, ...
Johnson & Johnson is collating its pantheon of medtech brands under a single banner, to further simplify the company’s ...
Johnson & Johnson (NYSE:JNJ) is currently experiencing a mix of robust growth and notable challenges. Recent developments ...
More than a decade after taking on Johnson & Johnson with the first trial linking baby powder to ovarian cancer, attorney ...
In a report released yesterday, Shagun Singh Chadha from RBC Capital maintained a Buy rating on Johnson & Johnson (JNJ – Research ...
Dakota Johnson is no stranger to the sheer dress trend. In fact, it’s practically her red carpet signature at this point. If ...
For her part, Daisy was rocking a textured, white, see-through crop top and matching shorts paired with a matching jacket, oversized slouchy brown bag, pearl necklace and a pair of brown suede flats ...
In a report released today, Joanne Wuensch from Citi reiterated a Buy rating on Johnson & Johnson (JNJ – Research Report). The ...
Bills coach Sean McDermott ruled out cornerback Taron Johnson (forearm) and linebacker Terrel Bernard (pectoral) for Monday ...
Johnson & Johnson (JNJ) closed the most recent trading day at $166.99, moving +0.89% from the previous trading session. The stock's performance was ahead of the S&P 500's daily gain of 0.13%. On the ...